NASDAQ
Oragenics, Inc. (OGEN) has a current ratio of 5.64x as of Monday, May 25, 2026. This represents a 27.62% decrease compared to its 12-month average of 7.79x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.